Editorial
Where are the Hearts?
Francis Robicsek* and Jeko Madjarov
Department of Thoracic and Cardiovascular Surgery, University of North Carolina, USA
*Corresponding author: Francis Robicsek, Department of Thoracic and Cardiovascular Surgery, University of North Carolina, 1001 Blythe Blvd. Charlotte, NC 28203, USA
Published: 06 Dec, 2017
Cite this article as: Robicsek F, Madjarov J. Where are the
Hearts?. Clin Surg. 2017; 2: 1804.
Editorial
Over 30 years ago President Reagan signed the National Organ Transplant Act (NOTA),
which established the federal legal framework for the procurement, donation and transplantation
of organs; the law's advocates hoped that it would end organ shortages, but today over 120,000
Americans are on waiting lists [1]. Several scientific forums [1-3] have addressed this vexing
problem, which does not seem to “go away”. The shortage of organs, especially hearts, available
for transplantation is undeniable. After the initial surge in the late eighties and early nineties, the
number of transplants leveled off, and in the last few years even fell, despite that the number of those
waiting in line for hearts has increased significantly. There is a critical shortage of organs available
for heart transplantation. Of an estimated 60,000 potential recipients fewer than 2,500 undergo
cardiac transplantation annually despite that by theoretical calculations ample number of donor
hearts should be available [2]. Thus one may ask: Where did the hearts disappear? The answer is
hearts are there, we just don’t get them! Some members of the profession recommend monetary
compensation for donated organs, paid either to living donors of kidneys, parts of liver or lungs,
or to the family of organs obtained in cadaveric donations. The amount of compensation may vary
from the cost of the funeral to outright payments to the family of heart donors. While this view
appears to be a “practical” solution, it would make organ-trafficking acceptable and would open a
“Pandora’s box “of not only for ethical but also criminal and legal issues, - some may recount the
medieval horrors of selling corpses for anatomical studies.
It would also raise the less gory, but certainly controversial issue comparable to the illegality of
prostitution. How could our society, for reasons of possible exploration, forbid an individual to be
compensated for temporary usage of their body, but condone permanently selling his or her body
parts?
Those of us who seek a solution to organ shortage, especially to the inadequate number of hearts
available for transplantation, must face all the “actors” of this danse macabre of desperate need. The
surgeon, who at the dawn of heart transplantation was a cause celebre', if not an international but at
least a local hero, today is only “just one of us”. The focus of professional and public attention shifted
to other issues, such as endovascular, minimally invasive, “off-pump” procedures, etc. Today, the
once heroic heart transplantation is but another entry on the long list of “other” cardiac interventions,
and may be done even by junior faculty barely out of training. In some institutions with “transplant
profiles” the surgeon may be under some pressure of “volume-performance”, but not in a scenario
we may find at an average cardio-thoracic department where only 20-24 heart transplants a year
are performed. Today, the surgical fee for a heart transplant is comparable to that of a valve repair,
despite that the former requires more time to coordinate, prepare and perform. It could also involve
flying small planes at night in stormy weather, dragging your off- duty partner into the hospital, and
cancelling pre-arranged operative schedule. Besides the surgeons desire to sincerely help “another”
patient, usually unknown to him previously, he has no incentive and certainly no time to prowl the
critical care units and look for potential donors! If a donor heart is made available, he will indeed
proceed with transplantation however, very few, if any, surgeons are out on the field searching for
organs themselves. After that said, however, it is also likely that in the mirror of falling numbers of
heart operations, our surgeons interest in heart transplantation may experience some revival. The
change in the general attitude of institutions regarding cardiac transplantation has been somewhat
similar. Subtle, but significant. Our hospitals initially enjoyed the publicity associated with heart
transplantations, nowadays most of them look upon the issue as a money-losing moral obligation,
similar to taking care of the uninsured in the Emergency Department. In the present economic
environment, in some institutions with “heart transplant profiles”, neither the surgeons nor the
hospital administrators appear to be eager to expand their transplant programs. Where does that
leave us? The pathway, described earlier to potentially improve the number of organs available for
transplantation, was to pay or even barter for organs. This would probably yield more hearts.
Would this help?
It might. However, even if we disregard the added cost, - a
price tag of $20,000/donor was mentioned- the ethical issue of
potential exploitation of the needy, would remain considerable if not
insurmountable. Some seek the solution in artificial hearts, which
are always “compatible” and just have to be taken of the shelf and
they are ready for implantation. However with their initial cost
of about $100,000 and a yearly expense of $200,000 maintenance,
may be a clinical, moral but certainly not a practical economical
solution. Significant and oftentimes devastating complications still
occur, despite the improvements in the VAD (Ventricular Assist
Device) technology and the constant work in risk modifying and
risk stratifying strategies [4,5]. If society really means what it says,
i.e. to discover a way to solve the donor organ shortage, we must
find a path that is both morally acceptable and economically feasible.
We stipulate that the goal of significantly increasing the number of
available donor hearts could be achieved with less cost and with little,
if any, ethical controversy, by redefining the role of the very important
third entity in organ procurement: the transplant coordinator. It is
not the intention of this Editorial to show any disrespect toward our
organ procurers, who often work hard in the wee-hours of the night
to obtain life-saving organs for our patients. They are, however, in
most instances nurses or professional assistants who have only onthe-
job training in organ procurement and lack special education
in the psychological and other aspects of how to deal with grieving,
occasionally hostile, family members who just lost a loved one or
may cling to an unreal hope of recovery from brain death. Notably,
our coordinators are paid an average mid-level nursing salary and
have little chance of progressing above that level, regardless of
their performance. Paying for hearts is an abyss, society should not
be eager to look into. We must seek alternatives. Measures already
applied or considered, such as loosening the criteria of acceptability
of donor organs and/or recipients are not a long term solution. We
also propose to spend a fraction of the funds we are evidently ready
to pay for organs and are already spending on long-term mechanical
heart support, to underwrite the expenses of hiring more transplant
coordinators, provide them with an adequate training which contains
elements of psychology, motivation and marketing as well. They
should also receive salaries that reflect not only their position, but
also their performance, i.e. the more hearts they “bring in” the more
money they may earn. If their performance should fall, so would their
income. If somebody may look at this arrangement as a tit-for-tat,
so be it!
It is a tit-for-tat!
Is this arrangement ethically objectionable? It may be for some.
But it is still better than tempting a father of starving children to sell
one of her/his kidneys. We should also provide maximal assistance
to our transplant personnel in their arduous task both in numbers
and in compensation. This approach would also be economical.
While to cover the need of a patient with a heart transplant it costs
30,000 to 40,000 a year to insert and maintain a patient on an artificial
heart costs about 200,000 annually. That covers the salary of about
three transplant procurers. If each of these brings in only two "extra"
donor hearts a year they have earned their salary! They should talk to
the family and the surgeon should also establish a rapport with the
family, if necessary. With all due respect to privacy and emotions, we
have to get more "aggressive". We may have to go as far as to show
the potential donor families the photograph of the potential recipient
desperately waiting for a transplant. If organ shortage is not a matter
of life and death, I don’t know what is? We have to reorganize our
organ procurement system. This is not our choice, it is our duty. To
accept and utilize this more active approach, we must be extremely
careful to assure that it becomes much more effective but without
being overly aggressive, especially in the context when approaching
grieving families. This is a difficult but with proper coaching, certainly
not an impossible task. We have to learn to channel emotions which
are working towards turning denial, into a wish to help those who are
in desperate need. To hire more and better trained organ procurers
would not necessarily exclude other measures. There could be some
compromise for direct monetary compensation for organs, but
it should certainly be short of direct payment for organs. We may
contribute to the funeral expenses of a heart donor or cover the
hospital expenses of a living organ contributor. But most of all we
need more and specially trained and well paid organ procurers who
understand and who show tact and respect, but also the degree of
tenacity and aggressiveness necessary for improved performance. We
should give it a try.
References
- Humphreys K. An organ shortage kills 30 Americans every day. Is it time to pay donors. The Washington Post. 2014.
- Russo MJ, Davies RR, Hong KN, Chen JM, Argenziano M, Moskowitz A, et al. Matching high-risk recipients with marginal donor hearts is a clinically effective strategy. Ann Thorac Surg. 2009;87(4):1066-70.
- Hippen B, Ross LF, Sade RM. Saving lives is more important than abstract more concerns: financial incentives should be used to increase organ donation. Ann Thorac Surg. 2009;88(4):1053-61.
- Acharya D, Loyaga-Rendon R, Morgan CJ, Sands KA, Pamboukian SV, Rajapreyar I, et al. INTERMACS Analysis of Stroke During Support With Continuous-Flow Left Ventricular Assist Devices: Risk Factors and Outcomes. JACC Heart Fail. 2017;5(10):703-11.
- Samsky M, Rogers JG. When VAD Things Happen to Good People. 2017.